Cetuximab biosimilar - OncobiologicsAlternative Names: ONS-1055
Latest Information Update: 14 Mar 2014
At a glance
- Originator Oncobiologics
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action Epidermal growth factor inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
- Available For Licensing Yes - Colorectal cancer; Head and neck cancer
Highest Development Phases
- Preclinical Colorectal cancer; Head and neck cancer